TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Depreciation USD 2010 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Teva Pharmaceutical Industries Ltd annual Depreciation history and growth rate from 2010 to 2023.
  • Teva Pharmaceutical Industries Ltd annual Depreciation for 2023 was $537 M, a 6.77% decline from 2022.
  • Teva Pharmaceutical Industries Ltd annual Depreciation for 2022 was $576 M, a 9.09% increase from 2021.
  • Teva Pharmaceutical Industries Ltd annual Depreciation for 2021 was $528 M, a 1.68% decline from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $537 M -$39 M -6.77% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-12
2022 $576 M +$48 M +9.09% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-12
2021 $528 M -$9 M -1.68% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-12
2020 $537 M -$72 M -11.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-10
2019 $609 M -$67 M -9.91% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-09
2018 $676 M +$44 M +6.96% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-10
2017 $632 M +$131 M +26.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $501 M +$52 M +11.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-02-12
2015 $449 M -$15 M -3.23% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-12
2014 $464 M +$6 M +1.31% Jan 1, 2014 Dec 31, 2014 20-F 2017-02-15
2013 $458 M +$30 M +7.01% Jan 1, 2013 Dec 31, 2013 20-F 2016-02-11
2012 $428 M +$70 M +19.6% Jan 1, 2012 Dec 31, 2012 20-F 2015-02-09
2011 $358 M -$90 M -20.1% Jan 1, 2011 Dec 31, 2011 20-F 2014-02-10
2010 $448 M Jan 1, 2010 Dec 31, 2010 20-F 2013-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.